Skip main navigation

Military Health System

Clear Your Cache

Health.mil has undergone a recent update. For the best user experience we recommend clearing your browser cache.

Surveillance Snapshot: Tick-borne Encephalitis in Military Health System Beneficiaries, 2012–2021

Image of Cover 4. iStock—The castor bean tick (Ixoedes ricinus). Credit: Erik Karits

Tick-borne encephalitis (TBE) is a viral infection of the central nervous system that is transmitted by the bite of infected ticks, mostly found in wooded habitats in parts of Europe and Asia.1 In Germany, the rate of 0.5 confirmed cases per 100,000 people in 2019 was the third highest of the 25 European countries reporting data on TBE.1 TBE has been of historical military significance because there are a large number of U.S. service members stationed in Germany, with an estimate of about 35,000 active duty members as of September 2021.2 In the Department of Defense (DOD) reportable medical event guidelines, TBE is a notifiable event listed under arboviral diseases.3

In August 2021, the U.S. Food and Drug Administration (FDA) approved a TBE vaccine (“TICOVAC”) for U.S. travelers visiting or living in endemic areas.4 In February 2022, the U.S. Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices (ACIP) voted to recommend Pfizer’s TICOVAC vaccine for use in U.S. populations who travel or move to endemic areas and will have extensive exposure to ticks based on their planned outdoor activities, including many service members serving in these locations.5

A 2019 MSMR report described the cases of TBE occurring among U.S. military service members and other beneficiaries between 2006 and 2018.6 This snapshot updates these results through the end of 2021 using confirmed and probable medical event reports of TBE cases contained in the U.S. military’s Disease Reporting System internet, with a focus on the past 10-year surveillance period.

The reported TBE cases between 2012 and 2018 have been previously described,6 consisting of 1 active component service member in 2012, 4 in 2017, and 3 other beneficiaries in 2018 (Figure). In 2019, there was 1 probable case reported in a 45 year-old male Army active component service member, and in 2020 there was 1 confirmed case in a 38 year-old male Army active component service member. In 2021, there were 2 cases reported: 1 probable case in a 6 year-old female Army dependent, and 1 probable case in a 34 year-old Army active component service member. All cases reported between 2019 and 2021 occurred in Germany in the months of June and July. Case comments were available for 2 of the 4 cases; both indicated that tick exposure likely occurred from living or exercising in a wooded area. None of the cases had a prior history of TBE vaccination.

The number of TBE cases per 5-year period among military health system beneficiaries grew from 1 in 2012–2016 to 11 in 2017–2021. Although the total number of cases is small, the increase in recent years provides information that should be considered when contemplating use of the FDA-approved vaccine for U.S. service members and beneficiaries who live or participate in extensive outdoor activities in a TBE-endemic area.

References

1. European Centre for Disease Prevention and Control. Tick-borne Encephalitis – Annual Epidemiologic report for 2019. Accessed 1 April 2022. https://www.ecdc.europa.eu/en/publications-data/tick-borne-encephalitis-annual-epidemiological-report-2019

2. Defense Manpower Data Center. Number of Military and DoD Appropriated Fund (APF) Civilian Personnel Permanently Assigned By Duty Location and Service/Component. September 30, 2021. Accessed 24 March 2022. https://dwp.dmdc.osd.mil/dwp/app/dod-data-reports/workforce-reports

3. Armed Forces Health Surveillance Branch. Armed Forces Reportable Medical Events, Guidelines and Case Definitions. January 2020. Accessed 2 April 2022. https://health.mil/Reference-Center/Publications/2020/01/01/Armed-Forces-Reportable-Medical-Events-Guidelines

4. Pfizer Press Release. U.S. FDA Approves TICOVAC, Pfizer’s Tick-Borne Encephalitis (TBE) Vaccine. 13 August 2021. Accessed 1 April 2022. https://www.pfizer.com/news/press-release/press-release-detail/us-fda-approves-ticovactm-pfizers-tick-borne-encephalitis

5. Pfizer Press Release. CDC Advisory Committee on Immunization Practices Votes to Recommend TICOVAC, Pfizer’s Tick-Borne Encephalitis (TBE) Vaccine, For Those at Risk of Virus Exposure. 23 February 2022. Accessed 1 April 2022. https://www.pfizer.com/news/press-release/press-release-detail/cdc-advisory-committee-immunization-practices-votes

6. Mancuso JD, Bazaco S, Stahlman S, Clausen SS, Cost AA. Tick-borne encephalitis surveillance in U.S. military service members and beneficiaries, 2006–2018. MSMR. 2019;26(11):4–10.

FIGURE. Confirmed or probable TBE cases among U.S. military service members and other beneficiaries, 2012–2021

 

 

You also may be interested in...

Topic
Mar 28, 2025

Medical Surveillance Monthly Report

The Medical Surveillance Monthly Report, a peer-reviewed journal launched in 1995, is the Armed Forces Health Surveillance Division's flagship publication. The MSMR provides monthly evidence-based estimates of the incidence, distribution, impact, and trends of health-related conditions among service members.

Article
Mar 1, 2025

Correlation Between Mean Temperature and Incidence of Tick-borne Diseases Among Active Duty Service Members in the Contiguous U.S., 2000–2023

This study identifies the incidence of the two tick-borne diseases, Lyme disease and Rocky Mountain spotted fever, that are most frequently diagnosed within the Military Health System among active component U.S. service members and evaluates the correlation between temperature and incidence of each tick-borne disease.

Article
Mar 1, 2025

Non-Medical Risk Factors Influencing Health and Association with Suicidal Ideation or Attempt, U.S. Active Component, 2018–2022

This study reports the prevalence of non-medical risk factors, also known as social determinants of health, among active component U.S. service members and assesses the relationship between these factors and suicide ideation or attempts between 2018 and 2022. This study documents, for the first time, the frequency of diagnosis for non-medical risk ...

Article
Feb 1, 2025

Development of a New Fleet Disease and Injury Surveillance Capability Using ESSENCE

This report details the steps taken to develop a timely, accurate, and comprehensive Navy fleet disease and injury surveillance capability, utilizing ESSENCE (Electronic Surveillance System for the Early Notification of Community-based Epidemics), including the successes and challenges that will guide further refinement and expansion of this tool.

Article
Feb 1, 2025

Surveillance Snapshot: Non-Hodgkin Lymphoma Incidence in Active Component U.S. Service Members, 2017–2023

This analysis utilizes an updated case definition for non-Hodgkin lymphoma developed by the Armed Forces Health Surveillance Division, based on consultation with subject matter experts and previous literature, to establish non-Hodgkin lymphoma incidence within the U.S. Armed Forces active component, from 2017 through 2023.

Article
Feb 1, 2025

External Cause Coding of Injury Encounters in the Military Health System Among Active Component U.S. Service Members, 2016–2019

Knowledge of injury causes is essential for prevention. This article describes causes of injury for all U.S. service members, from 2016 through 2019, and identifies variations in injury cause coding over time, and by branch of military service, type of health care visit and facility, and diagnosis category.

Article
Jan 1, 2025

Use of Positive Predictive Value to Evaluate the Armed Forces Health Surveillance Division Brain Cancer Incidence Rules, Active Component Department of the Air Force Pediatric Dependent Population, January 1, 2010–December 31, 2020

This study applied the Armed Forces Health Surveillance Division (AFHSD) case definition for the identification of malignant brain tumors among U.S. active service members to the dependent pediatric population of the active component of the U.S. Air Force, to determine the positive predictive value of this case definition for a pediatric population.

Skip subpage navigation
Refine your search
Last Updated: July 11, 2023
Follow us on Instagram Follow us on LinkedIn Follow us on Facebook Follow us on X Follow us on YouTube Sign up on GovDelivery